Reuters: Private Equity: UPDATE 1-India's Intas to raise 3 bln rupees from ChrysCap

Reuters: Private Equity Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

UPDATE 1-India's Intas to raise 3 bln rupees from ChrysCap Apr 25th 2012, 07:56 Wed Apr 25, 2012 3:56am EDT (Adds details) MUMBAI, April 25 (Reuters) - Indian drugmaker Intas Pharmaceuticals said it was raising 3 billion rupees ($57 million) from private equity firm ChrysCapital ahead of its initial public offering. The Ahmedabad-based company said the funds will be used to expand operations and retire part of its debt. Intas will look at launching its IPO, for which it has got approval from the regulator, only next year because of market volatility, Vice-Chairman and Managing Director Binish Chudgar said. ChrysCapital, which holds 11.3 percent in the company, will increase its holding, ChrysCapital said. ChrysCapital will make a partial or full exit during the public offer, said Sanjiv Kaul, managing director, ChrysCapital. Intas will go for no more funding before the listing, Chudgar said. Private-equity firms invested about $1.9 billion in Indian companies during the quarter ended March 2012, down about 30 percent from last year, according industry tracker, VCCircle.com due to crowded markets and higher valuations. India's stock market dropped nearly 25 percent in 2011, making it one of the worst global performers and leaving few options for private equity firms to exit from their portfolio companies through IPOs or block deals. However, the benchmark index has risen 10.15 percent so far this year. Intas has revenues of 27 billion rupees with 40 percent from exports and has strong presence in chronic therapy areas like cardio and central nervous system. ($1 = 52.77 rupees) (Reporting by Sanjeev Choudhary; Editing by Rajesh Pandathil) Link this Share this Digg this Email Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions